Trial intelligence / Profile preview

Meperidine vs dexamethasone vs midazolam for postoperative shivering after orthopedic surgery

IRCT20211226053537N1Phase 3Completed

Sponsor
Alborz University of Medical Sciences
Start
Feb 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postanesthetic shivering (PAS) comparing Meperidine, Dexamethasone and Midazolam (3 arms). Primary endpoint: Shivering after surgery with general anesthesia. Started Feb 2022; status: completed.

02

Drugs

pethidinedexamethasonemidazolam
03

Conditions

postanesthetic shivering (PAS)

Beyond the preview

Go deeper on IRCT20211226053537N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20211226053537N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call